MARTINELLI, Sara
 Distribuzione geografica
Continente #
NA - Nord America 1.539
EU - Europa 411
AS - Asia 266
OC - Oceania 1
Totale 2.217
Nazione #
US - Stati Uniti d'America 1.539
CN - Cina 168
IT - Italia 104
TR - Turchia 91
DE - Germania 75
UA - Ucraina 65
GB - Regno Unito 62
SE - Svezia 43
FI - Finlandia 19
BE - Belgio 16
FR - Francia 11
RU - Federazione Russa 7
IE - Irlanda 3
NL - Olanda 3
KR - Corea 2
AT - Austria 1
AU - Australia 1
ES - Italia 1
HK - Hong Kong 1
IN - India 1
IR - Iran 1
MK - Macedonia 1
MY - Malesia 1
UZ - Uzbekistan 1
Totale 2.217
Città #
Woodbridge 217
Fairfield 208
Ann Arbor 168
Chandler 144
Houston 112
Jacksonville 82
Ashburn 78
Wilmington 71
Seattle 69
Beijing 66
Cambridge 65
Ferrara 46
Izmir 45
New York 40
Nanjing 31
Princeton 22
Milan 21
Shanghai 21
Boardman 20
Addison 19
San Diego 17
Brussels 16
Bremen 12
Shenyang 11
Nanchang 8
Changsha 7
Falls Church 5
Tianjin 5
Dearborn 4
Jinan 4
London 4
Ningbo 4
Des Moines 3
Dublin 3
Illasi 3
Mountain View 3
Orange 3
Redwood City 3
Auburn Hills 2
Augusta 2
Hebei 2
Hefei 2
Jiaxing 2
Los Angeles 2
Norwalk 2
Anzola Dell'emilia 1
Ardabil 1
Bologna 1
Central 1
Colico 1
Hangzhou 1
Hounslow 1
Johor Bahru 1
Kunming 1
La Coruña 1
Lanzhou 1
Leawood 1
Melbourne 1
Monmouth Junction 1
Pescara 1
Redmond 1
San Francisco 1
San Mateo 1
Seoul 1
Simi Valley 1
Stockholm 1
Taizhou 1
Torino 1
Velp 1
Vienna 1
Washington 1
Zhengzhou 1
Totale 1.701
Nome #
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 150
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 131
null 124
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 124
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 122
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 120
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 119
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 116
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia. 115
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 113
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 113
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 111
Delirium in acute promyelocytic leukemia patients: two case reports. 110
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 105
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 92
null 88
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 87
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 86
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 72
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 67
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone 57
Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion 16
Complete remission of Sweet's syndrome after azacytidine treatment for concomitant myelodysplastic syndrome 16
Totale 2.254
Categoria #
all - tutte 8.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019114 0 0 0 0 0 0 0 0 0 0 0 114
2019/2020481 74 13 21 70 34 56 47 41 47 46 19 13
2020/2021334 17 19 16 41 19 37 16 34 4 38 62 31
2021/2022287 34 21 11 8 13 17 23 15 8 28 30 79
2022/2023299 29 29 10 46 53 34 24 21 33 0 14 6
2023/2024112 15 13 4 2 4 48 9 7 3 2 0 5
Totale 2.254